Research output per year
Research output per year
Personal profile
Headline
PROFESSOR Medicine, Cardiology
Fingerprint
Dive into the research topics where Juan Badimon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies during Acute Myocardial Infarction
Santos-Gallego, C. G., Requena-Ibáñez, J. A., Picatoste, B., Fardman, B., Ishikawa, K., Mazurek, R., Pieper, M., Sartori, S., Rodriguez-Capitán, J., Fuster, V. & Badimon, J. J., 1 Apr 2023, In: Circulation: Cardiovascular Imaging. 16, 4, p. E015298Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Pérez, M. S., Rodríguez-Capitán, J., Requena-Ibáñez, J. A., Santos-Gallego, C. G., Urooj Zafar, M., Escolar, G., Mancini, D., Mitter, S., Lam, D., Contreras, J. P., Fergus, I., Atallah-Lajam, F., Abascal, V., Lala, A., Moreno, P., Moss, N., Lerakis, S., Sanz, J., Fuster, V. & Badimon, J. J., 2023, (Accepted/In press) In: Cardiovascular Drugs and Therapy.Research output: Contribution to journal › Review article › peer-review
-
Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors
Vargas-Delgado, A. P., Arteaga Herrera, E., Tumbaco Mite, C., Delgado Cedeno, P., Van Loon, M. C. & Badimon, J. J., Feb 2023, In: International Journal of Molecular Sciences. 24, 4, 4144.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Effects of electret coating technology on coronary stent thrombogenicity
Zafar, M. U., Bravo-Cordero, J. J., Torramade-Moix, S., Escolar, G., Jerez-Dolz, D., Lev, E. I. & Badimon, J. J., 2022, In: Platelets. 33, 2, p. 312-319 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial
Requena-Ibáñez, J. A., Santos-Gallego, C. G., Rodriguez-Cordero, A., Vargas-Delgado, A. P. & Badimón, J. J., Feb 2022, In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 16, 2, 102417.Research output: Contribution to journal › Article › peer-review
19 Scopus citations
Press/Media
-
New Heart Failure Study Findings Have Been Reported by Investigators at Icahn School of Medicine at Mount Sinai [Rationale and Design of the Sota-p-cardia Trial (Atru-v): Sotagliflozin In Hfpef Patients Without Diabetes]
David Lam, Vivian Abascal,, Noah Moss, Valentin Fuster, Angel Sanz Salvo, Sumeet Mitter, Donna Mancini, David Lam, Juan Badimon & Stamatios Lerakis
14/07/23
1 item of Media coverage
Press/Media
-
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits
26/07/21
1 item of Media coverage
Press/Media
-
EMPA-TROPISM: Empagliflozin improves LV remodeling in patients with heart failure
20/01/21
1 item of Media coverage
Press/Media
-
Empagliflozin LV remodeling not reliant on glucose lowering
25/11/20
1 item of Media coverage
Press/Media
-
Empagliflozin Also Beneficial in Heart-Failure Patients Without Diabetes
25/11/20
1 item of Media coverage
Press/Media